NFL BIOSCIENCES SA (ALNFL.PA) Fundamental Analysis & Valuation
EPA:ALNFL • FR0014003XT0
Current stock price
1.11 EUR
-0.01 (-1.07%)
Last:
This ALNFL.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ALNFL.PA Profitability Analysis
1.1 Basic Checks
- ALNFL had negative earnings in the past year.
- ALNFL had negative earnings in each of the past 5 years.
- ALNFL had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- ALNFL's Return On Assets of -50.64% is on the low side compared to the rest of the industry. ALNFL is outperformed by 65.00% of its industry peers.
- ALNFL has a Return On Equity (-84.25%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -50.64% | ||
| ROE | -84.25% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for ALNFL so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ALNFL.PA Health Analysis
2.1 Basic Checks
- Compared to 1 year ago, ALNFL has more shares outstanding
- Compared to 5 years ago, ALNFL has more shares outstanding
- Compared to 1 year ago, ALNFL has an improved debt to assets ratio.
2.2 Solvency
- ALNFL has an Altman-Z score of 3.88. This indicates that ALNFL is financially healthy and has little risk of bankruptcy at the moment.
- ALNFL's Altman-Z score of 3.88 is fine compared to the rest of the industry. ALNFL outperforms 70.00% of its industry peers.
- ALNFL has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
- ALNFL has a better Debt to Equity ratio (0.01) than 83.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.88 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 2.35 indicates that ALNFL has no problem at all paying its short term obligations.
- ALNFL has a Current ratio (2.35) which is in line with its industry peers.
- A Quick Ratio of 2.35 indicates that ALNFL has no problem at all paying its short term obligations.
- The Quick ratio of ALNFL (2.35) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 |
3. ALNFL.PA Growth Analysis
3.1 Past
- ALNFL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.35%, which is quite impressive.
EPS 1Y (TTM)54.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-423.53%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 85.12% on average over the next years. This is a very strong growth
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-93.75%
EPS Next 2Y-81.43%
EPS Next 3Y85.12%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. ALNFL.PA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ALNFL. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALNFL. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as ALNFL's earnings are expected to grow with 85.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-81.43%
EPS Next 3Y85.12%
5. ALNFL.PA Dividend Analysis
5.1 Amount
- No dividends for ALNFL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ALNFL.PA Fundamentals: All Metrics, Ratios and Statistics
EPA:ALNFL (3/13/2026, 7:00:00 PM)
1.11
-0.01 (-1.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner ChangeN/A
Ins Owners17.79%
Ins Owner ChangeN/A
Market Cap14.06M
Revenue(TTM)N/A
Net Income(TTM)-1.83M
Analysts81.82
Price Target2.99 (169.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 6.48 | ||
| P/tB | 6.96 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.36
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.17
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -50.64% | ||
| ROE | -84.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 | ||
| Altman-Z | 3.88 |
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-423.53%
EPS Next Y-93.75%
EPS Next 2Y-81.43%
EPS Next 3Y85.12%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-136.84%
EBIT Next 3Y94.59%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A
NFL BIOSCIENCES SA / ALNFL.PA Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for NFL BIOSCIENCES SA?
ChartMill assigns a fundamental rating of 2 / 10 to ALNFL.PA.
What is the valuation status of NFL BIOSCIENCES SA (ALNFL.PA) stock?
ChartMill assigns a valuation rating of 1 / 10 to NFL BIOSCIENCES SA (ALNFL.PA). This can be considered as Overvalued.
What is the profitability of ALNFL stock?
NFL BIOSCIENCES SA (ALNFL.PA) has a profitability rating of 0 / 10.
How financially healthy is NFL BIOSCIENCES SA?
The financial health rating of NFL BIOSCIENCES SA (ALNFL.PA) is 5 / 10.